Propagenix
About:
Propagenix is focuses on development and commercialization of products to support applications in translational biomedical research.
Website: http://www.propagenix.com
Top Investors: Virginia Catalyst
Description:
Propagenix is a healthcare technology platform developer that aims to provide individualized diagnostics and cell therapies to improve human health. The company's systems are used in advanced therapies in development to differentiate primary epithelial adult stem cells for use in tissue models for drug discovery and toxicology screening, allowing medical professionals to address the acute shortage of transplantable organs that require mature, functional epithelial tissues such as skin, airways, and kidneys.
$9.23M
$1M to $10M
Rockville, Maryland, United States
2014-04-11
Brian A. Pollok, Richard Schlegel, Sharon Challberg
1-10
2017-06-21
Private
© 2025 bioDAO.ai